BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 20194689)

  • 21. Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.
    Chaorattanakawee S; Saunders DL; Sea D; Chanarat N; Yingyuen K; Sundrakes S; Saingam P; Buathong N; Sriwichai S; Chann S; Se Y; Yom Y; Heng TK; Kong N; Kuntawunginn W; Tangthongchaiwiriya K; Jacob C; Takala-Harrison S; Plowe C; Lin JT; Chuor CM; Prom S; Tyner SD; Gosi P; Teja-Isavadharm P; Lon C; Lanteri CA
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4631-43. PubMed ID: 26014942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro susceptibility of Plasmodium falciparum isolates in Vietnam to artemisinin derivatives and other antimalarials.
    Wongsrichanalai C; Nguyen TD; Trieu NT; Wimonwattrawatee T; Sookto P; Heppner DG; Kawamoto F
    Acta Trop; 1997 Feb; 63(2-3):151-8. PubMed ID: 9088428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between Polymorphisms in the Pf
    Gendrot M; Diawara S; Madamet M; Kounta MB; Briolant S; Wade KA; Fall M; Benoit N; Nakoulima A; Amalvict R; Diémé Y; Fall B; Wade B; Diatta B; Pradines B
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand.
    Chaorattanakawee S; Lon C; Jongsakul K; Gawee J; Sok S; Sundrakes S; Kong N; Thamnurak C; Chann S; Chattrakarn S; Praditpol C; Buathong N; Uthaimongkol N; Smith P; Sirisopana N; Huy R; Prom S; Fukuda MM; Bethell D; Walsh DS; Lanteri C; Saunders D
    Malar J; 2016 Oct; 15(1):519. PubMed ID: 27769299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug resistance and in vitro susceptibility of Plasmodium falciparum in Thailand during 1988-2003.
    Suwandittakul N; Chaijaroenkul W; Harnyuttanakorn P; Mungthin M; Na Bangchang K
    Korean J Parasitol; 2009 Jun; 47(2):139-44. PubMed ID: 19488420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis of pfatp6 and pfmdr1 polymorphisms and their association with in vitro sensitivity in Plasmodium falciparum isolates from the Thai-Myanmar border.
    Phompradit P; Wisedpanichkij R; Muhamad P; Chaijaroenkul W; Na-Bangchang K
    Acta Trop; 2011; 120(1-2):130-5. PubMed ID: 21777558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevalence and degree of resistance of Plasmodium falciparum to first-line antimalarial drugs: an in vitro study from a malaria endemic region in Yemen.
    Al-Shamahy H; Al-Harazy AH; Harmal NS; Al-Kabsi AM
    Ann Saudi Med; 2007; 27(6):432-6. PubMed ID: 18059124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and characterization of piperaquine, mefloquine and artemisinin derivatives triple-resistant Plasmodium falciparum in Cambodia.
    Mairet-Khedim M; Roesch C; Khim N; Srun S; Bouillon A; Kim S; Ke S; Kauy C; Kloeung N; Eam R; Khean C; Kul C; Chy S; Leang R; Ringwald P; Barale JC; Witkowski B
    J Antimicrob Chemother; 2023 Feb; 78(2):411-417. PubMed ID: 36508338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of artesunate combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro.
    Fivelman QL; Walden JC; Smith PJ; Folb PI; Barnes KI
    Trans R Soc Trop Med Hyg; 1999; 93(4):429-32. PubMed ID: 10674097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ex-vivo Sensitivity of Plasmodium falciparum to Common Anti-malarial Drugs: The Case of Kéniéroba, a Malaria Endemic Village in Mali.
    Traoré K; Diakité SAS; Bah S; Konaté DS; Dabitao D; Sanogo I; Sangaré M; Dama S; Keita B; Doumbouya M; Guindo MA; Doumbia S; Diakité M
    Drugs R D; 2020 Sep; 20(3):249-255. PubMed ID: 32557086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998-2009.
    Thanh NV; Toan TQ; Cowman AF; Casey GJ; Phuc BQ; Tien NT; Hung NM; Biggs BA
    Malar J; 2010 Jun; 9():181. PubMed ID: 20573274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro antimalarial drug susceptibility in Thai border areas from 1998-2003.
    Chaijaroenkul W; Bangchang KN; Mungthin M; Ward SA
    Malar J; 2005 Aug; 4():37. PubMed ID: 16060967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine.
    Brockman A; Price RN; van Vugt M; Heppner DG; Walsh D; Sookto P; Wimonwattrawatee T; Looareesuwan S; White NJ; Nosten F
    Trans R Soc Trop Med Hyg; 2000; 94(5):537-44. PubMed ID: 11132385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-resistant malaria in Bangladesh: an in vitro assessment.
    Noedl H; Faiz MA; Yunus EB; Rahman MR; Hossain MA; Samad R; Miller RS; Pang LW; Wongsrichanalai C
    Am J Trop Med Hyg; 2003 Feb; 68(2):140-2. PubMed ID: 12641401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia.
    Leang R; Ros S; Duong S; Navaratnam V; Lim P; Ariey F; Kiechel JR; Ménard D; Taylor WR
    Malar J; 2013 Sep; 12():343. PubMed ID: 24060207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of artemisinin derivatives against African isolates and clones of Plasmodium falciparum.
    Basco LK; Le Bras J
    Am J Trop Med Hyg; 1993 Sep; 49(3):301-7. PubMed ID: 8372953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs.
    Skinner TS; Manning LS; Johnston WA; Davis TM
    Int J Parasitol; 1996 May; 26(5):519-25. PubMed ID: 8818732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic polymorphisms of candidate markers and in vitro susceptibility of Plasmodium falciparum isolates from Thai-Myanmar border in relation to clinical response to artesunate-mefloquine combination.
    Phompradit P; Muhamad P; Chaijaroenkul W; Na-Bangchang K
    Acta Trop; 2014 Nov; 139():77-83. PubMed ID: 25004442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro sensitivity of Plasmodium falciparum to chloroquine, halofantrine, mefloquine and quinine in Madagascar.
    Randrianarivelojosia M; Ratsimbasoa A; Randrianasolo L; Randrianarijaona A; Jambou R
    East Afr Med J; 2002 May; 79(5):237-41. PubMed ID: 12638806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin.
    Sidhu AB; Uhlemann AC; Valderramos SG; Valderramos JC; Krishna S; Fidock DA
    J Infect Dis; 2006 Aug; 194(4):528-35. PubMed ID: 16845638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.